This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
ResultsThe bibliometric analysis of COVID-19 and SuddenCardiacDeath highlights key research trends from 2020 to 2024, revealing a rapid surge in scientific output during the pandemic. being original research, reflecting a strong focus on new empirical evidence. 2,915 articles were retrieved, with 70.5%
For more than 30 years, Cardiac Risk in the Young (CRY) has been at the forefront of efforts to prevent suddencardiacdeaths in young people. Established in 1995, CRY has transformed the landscape of cardiac screening, research, and bereavement support in the UK and beyond.
ABSTRACT Suddencardiacdeath (SCD) is a major public health challenge, resulting in significant loss of life each year. Thus far, relatively few studies have investigated this dynamic risk concept, underscoring the need for further research including validation in larger, prospective studies and clinical trials.
This study by Fujita Health University researchers revealed that kidney function, considered in terms of estimated glomerular filtration rate (eGFR), can be used as a predictor for SCD in patients with congestive heart failure. During the follow-up period, 198 of these patients suffered from SCD.
Image courtesy of UCL Institute of Cardiovascular Science / James Tye milla1cf Tue, 12/19/2023 - 18:19 December 19, 2023 — A vest that can map the electrical activity of the heart in fine detail could potentially be used to better identify people at high risk of suddencardiacdeath , suggests a new study led by UCL researchers.
A reusable vest that can map the electrical activity of the heart in fine detail could potentially be used to better identify people at high risk of suddencardiacdeath, suggests a new study led by UCL researchers.
A heart attack is a life-threatening condition, with patients remaining at risk of premature death long after the actual attack—50% to 60% of patients die subsequently as a result of suddencardiacdeath, triggered by cardiac arrhythmia.
Although the 2024 ACC/American Heart Association (AHA) and 2023 European Society of Cardiology (ESC) guidelines stratify well overall the risk of suddencardiacdeath (SCD) in patients with hypertrophic cardiomyopathy (HCM).
Research Highlights: While the overall incidence of suddencardiacdeath among National Collegiate Athletic Association athletes decreased over. This abstract is simultaneously published with a full manuscript in the AHA’s flagship journal Circulation.
Barr’s death at 39 from suddencardiac arrest was caused by mitral valve prolapse—a heart valve defect that can affect the heart’s ability to pump blood. It can, in some cases, lead to death. The PRIMARY trial is directed by Joanna Chikwe, MD, chair of the Department of Cardiac Surgery at Cedars-Sinai.
Seidman, Christine E, Meder, Benjamin, Sinagra, Gianfranco were the most productive authors, German Centre for Cardiovascular Research was the most productive institution, and the USA, China, and Germany were the most prolific countries. Notable advances have been achieved in discovering and understanding the genetics of DCM.
In his year-long term as President of HVS, Dr. El-Hamamsy will focus on fostering collaboration among cardiologists, surgeons, and researchers, as well as promoting awareness and encouraging innovation to reduce the burden of heart valve disease globally.
A new computational method developed by physicists at Tampere University can be used to estimate the risk of suddencardiacdeath from a one-minute heart rate measurement at rest. The study was carried out in interdisciplinary collaboration between cardiology and computational physics.
The study, titled " Targeted Therapy with Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy " (TaRGET), will be led by the research team at PHRI and will involve collaboration with multiple organizations in addition to AMO Pharma including the Hearts in Rhythm Organization (HiRO).
Approximately half the OCM cases were diagnosed with suddencardiacdeath (SCD), with significant differences. Macroscopically, OCM hearts had a “globoid” appearance with a thickened right ventricular outflow tract. Some OCM cases showed focal interstitial fibrosis in the left ventricle.
The effects of SGLT2i on atrial fibrillation(AF), atrial flutter(AFL), composite AF/AFL, ventricular fibrillation(VF), ventricular tachycardia(VT), ventricular extrasystoles(VES), suddencardiacdeath(SCD) and composite VF/VT/SCD were evaluated. The mean age was 64.9 ± 9.4 ± 9.4 were male.
Suddencardiacdeath (SCD) in obesity is the focus of a JACC: State-of-the-Art review of the mechanisms as well as current evidence for its management, gaps in knowledge and future research, published in JACC.
Abstract The limited literature and increasing interest in studies on cardiac electrophysiology, explicitly focusing on cardiac ion channelopathies and suddencardiacdeath in diverse populations, has prompted a comprehensive examination of existing research.
Dilated cardiomyopathy (DCM) is a common heart muscle disorder of nonischemic etiology associated with heart failure development and the risk of malignant ventricular arrhythmias and suddencardiacdeath.
Predicting suddencardiacdeath may be possible using artificial intelligence (AI) to analyze medical information in electronic health records, according to preliminary research.
In an original investigation presented at the Cardiology Research Technology conference in Washington, D.C. Smith Center for Outcomes Research in Cardiology and section chief of Interventional Cardiology at BIDMC. Yeh , MD, MSc, MBA, director of the Richard A. and Susan F. Allocco, MD, Boston Scientific Corporation.
Researchers Elizabeth Jordan and Ray Hershberger, MD discuss the results of genetic tests that indicate a risk for dilated cardiomyopathy. Using mathematical modeling techniques, researchers estimated that 30% of patients with DCM had at least one first-degree family member (child, sibling or parent) with DCM.
The incidence of myocardial infarction (MI) and suddencardiacdeath (SCD) is significantly higher in individuals with Type 2 Diabetes Mellitus (T2DM) than in the general population. Strategies for the prevent.
“I am grateful to my ACC colleagues for recognizing our work with this prestigious award,” said Chugh, associate director of the Smidt Heart Institute and the Pauline and Harold Price Chair in Cardiac Electrophysiology Research at Cedars-Sinai. Chugh’s research is funded by the National Heart, Lung, and Blood Institute.
During the intravenous lacosamide infusion, the patient developed suddencardiac arrest caused by ventricular arrhythmias necessitating resuscitation. Of note, the patient had a family history of suddencardiacdeath.
The “Breakthrough” value proposition of AutoChamber AI for population health lies in its ability to opportunistically screen millions of CT scans that are done for other reasons and help doctors detect high-risk patients for cardiovascular disease (CVD) and suddencardiacdeath (SCD).
Since its identification in 1981 its diagnosis has increased due to the advancements in cardiac imaging. It’s association with ventricular arrythmia (VA) and suddencardiacdeath (SCD) underscores the importance of its identification. Its implications in VA and SCD warrant further research.
BACKGROUND:No disease-specific therapy currently exists for arrhythmogenic right ventricular cardiomyopathy (ARVC), a progressive cardiogenetic condition conferring elevated risk for ventricular arrhythmias, heart failure, and suddencardiacdeath. Emerging gene therapies have the potential to fill this gap.
To improve arrhythmogenic cardiomyopathy (ACM) patient care four pillars of ACM research are necessary. Research in a plakophilin-2-deficient mouse model suggests this antiarrhythmic drug may be particularly useful for patients with likely pathogenic or pathogenic (LP/P) PKP2 variants.
It presents in acute, indeterminate, and chronic phases, with chronic cardiomyopathy being the most severe form, leading to heart failure, arrhythmias, and suddencardiacdeath. While promising, further research is needed to establish the clinical significance and impact of these techniques in routine practice.
Prior research in suddencardiacdeath (SCD) genetics has focused on selected populations such as the young or “autopsy” negative. These studies neglect older decedents or those with cardiovascular (CV) pathology (e.g., coronary artery disease [CAD]), which comprise the majority of SCD.
It causes the heart muscle to become stiff and thick, making it harder for the heart to pump blood properly and increasing the risk of suddencardiacdeath. For the phase 2 trial, researchers enrolled 67 patients treated for nonobstructive HCM at 14 centers.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a disease characterised by fibrofatty replacement of the ventricular myocardium due to specific mutations, leading to ventricular arrhythmias and suddencardiacdeath. Future therapies, such as adenoviruses and GSk3b modulation, are still in early-stage research.
New HCM Guidelines Updated recommendations in the guideline reflect recent evidence about HCM treatment and management including new forms of pharmacologic management; participation in vigorous recreational activities and competitive sports; and risk stratification for suddencardiacdeath (SCD) with an emphasis on pediatric patients.
Vice President, Head of Clinical Research. Risk factors of suddencardiacdeath in hypertrophic cardiomyopathy. Included in these assessments are a complete hemodynamic response which was demonstrated in two-thirds of the patients in SEQUOIA-HCM,” said Stephen Heitner, M.D., Hong Y, Su WW, Li X.
While US public health authorities have been convinced from the very beginning about how safe and effective the new vaccines are, researchers in other countries with far smaller budgets have been testing that theory. This identified eight cases of suddencardiacdeath as caused by VRM that were not known until the autopsy was performed.
7 Research has shown inflammation plays a significant role in the development of atherosclerosis and ASCVD,8-10 and even the formation of plaque.11 However, the development of atherosclerosis is now known to be much more complex, with a key role for immune cells and inflammation in conjunction with hyperlipidemia and elevated LDL levels.7
I remember Allie well from her days in the Research volunteer program at Hennepin. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of suddencardiacdeath. This was submitted by Alexandra Schick. The article is edited by Smith. Heart Rhythm, 15(9): 1394-1401. [7]
There are only a few elite academic trialist groups capable of running large trials and there’s ample reason to be suspicious about the nexus that has developed between academia and the pharmaceutical companies that shower them with cash to hopefully get a positive study result and pay off the pharmaceutical research investment manifold.
Other Research: According to this study b y Batchvarov et al. , We are not using any human or patient data; we are only comparing the rule-of-thumb to various formulas, which may or may not be correspondingly validated by health data (the risk of suddencardiacdeath, for instance). In this study by Hasanien et al. ,
The authors are very careful to not use definitive causal terms, but it is pretty clear they strongly believe they are describing a new mechanism and novel etiology of suddencardiacdeath. Anish Koka is a cardiologist. Follow him on twitter @anish_koka.
IntroductionThe diagnostic performance of automated analysis of electrocardiograms for screening children with pediatric heart diseases at risk of suddencardiacdeath is unknown.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content